ALLMedicine™ Atopic Keratoconjunctivitis Center
Research & Reviews 63 results
European Journal of Ophthalmology; Ghiglioni DG, Zicari AM et. al.
Jun 2nd, 2021 - Vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC) are potentially severe and complex disease in its management among the various allergic eye diseases. In this regard, studies clarified the etiopathogenetic mechanisms. The wo...
The Journal of Allergy and Clinical Immunology; Nunomura S, Kitajima I et. al.
May 29th, 2021 - Atopic keratoconjunctivitis (AKC) is a chronic allergic conjunctival disease. However, a mouse model of AKC to investigate the underlying mechanism and to estimate the efficacy of the therapeutic agents has not been established. We recently genera...
Allergy Messina A, Palmigiano A et. al.
Feb 15th, 2021 - Tear fluid N-Glycome from patients affected with vernal (VKC) and atopic keratoconjunctivitis (AKC) was investigated to identify specific changes in tears and to recognize possible glyco-biomarkers. The analysis of the N-glycans was performed usin...
Current Eye Research; Shiraki Y, Shoji J et. al.
Jan 12th, 2021 - To investigate whether crude house-dust-mite antigen exacerbates eosinophilic inflammation in the conjunctival tissues of an atopic keratoconjunctivitis mouse model in a dose-dependent manner. An atopic keratoconjunctivitis mouse model was establi...
The Cochrane Database of Systematic Reviews; Kim SE, Nowak V et. al.
Oct 22nd, 2020 - Atopic keratoconjunctivitis (AKC) and vernal keratoconjunctivitis (VKC) are severe and potentially sight-threatening allergic eye diseases characterised by chronic inflammation of the ocular surface. Both topical and systemic treatments are used. ...
Clinicaltrials.gov 3 results
Aug 29th, 2019 - This is a Phase 1b, open-label, study to assess the effects of AK002, given as monthly intravenous infusion for 6 doses at up to 3 mg/kg.
Jun 14th, 2018 - Treatment of vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC) is a challenge for the ophthalmologist and patients because of its wide variation in presentation and recurrence in nature. Patients has to be dependent on long t...
Nov 5th, 2012 - This study evaluates the efficacy and safety of Cyclosporine 0.010% eye drops in the treatment of Atopic Keratoconjunctivitis (chronic and severe inflammation of the eye). The study consists of a double-masked phase, and open-labeled phase, and an...